DATS stock recently surged to $6.63, recovering from a sharp drop to $3.22 after a $5.1 million direct offering announcement caused dilution concerns. The bullish view hinges on speculative interest and potential for further recovery, with a near-term target of $7.50 if momentum sustains. However, the stock remains volatile, driven by sentiment rather than fundamentals.